文献速递治疗药物监测与药物基因组学肝肾功能剂量调整药物不良反应与药物警戒

万古霉素持续输注的给药剂量与暴露:一项回顾性研究

Dosing and Exposure of Vancomycin With Continuous Infusion: A Retrospective Study.
PubMed 文献 · Clin Pharmacol Ther · 2024-02-26

结果显示该方案暴露过高,仅25%样本在17-25 mg/L目标窗内,89%的eGFR 50-80 mL/min且剂量40-60 mg/kg/日的样本超治疗浓度,建议降低剂量并根据肾功能调整。

要点

  • 45 mg/kg/日方案暴露过高,仅25%样本在17-25 mg/L目标窗内。
  • eGFR 50-80 mL/min且剂量40-60 mg/kg/日者89%超治疗浓度。
  • 浓度≥40 mg/L时需先排除采样错误再调整剂量。

核心结论

  • 45 mg/kg/日经验性给药导致万古霉素暴露过高,建议降低剂量并根据肾功能区分给药。

研究设计与样本

  • 排除18岁以下、接受肾脏替代治疗、肌酐清除率降低(CKD-EPI < 50 mL/min/1.73 m²)或门诊抗生素治疗的患者。
  • 初始纳入121个样本,后排除7个采样不正确的样本(其中6个浓度≥40 mg/L)。

主要发现

  • 剂量40-50 mg/kg/日时浓度范围为18.4-61.0 mg/L。
  • 仅25%样本在17-25 mg/L目标窗内,15%样本浓度≥40 mg/L。
  • eGFR 50-80 mL/min且剂量40-60 mg/kg/日的患者中89%样本超治疗浓度。

关键数值与推荐

  • 目标浓度窗为17-25 mg/L。
  • 负荷剂量20 mg/kg,维持剂量45 mg/kg/日(原文评估方案)。
  • 浓度≥40 mg/L时需排除采样不正确后再调整剂量。

临床怎么用

  • 避免经验性使用45 mg/kg/日持续输注,应根据肾功能降低剂量。
  • 监测浓度≥40 mg/L时先排除采样错误再调整剂量。
  • 患者间暴露变异大,需及时进行治疗药物监测。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Vancomycin continuous infusion (CI) has suggested benefits over intermittent infusion: reduced nephrotoxicity, higher target attainment, and simpler therapeutic drug monitoring (TDM). Empiric dosing regimens range from 30-60 mg/kg/day and it is unclear which regimen results in optimal exposure. This study evaluates whether a dosing regimen of 45 mg/kg/day after a 20 mg/kg loading dose for patients with estimated glomerular filtration rate (eGFR) ≥ 50 mL/min results in adequate exposure. We retrospectively analyzed plasma concentrations from patients treated with vancomycin CI as routine clinical care between February and October 2021. Patients under 18 years old, with renal replacement therapy, reduced creatinine clearance (Chronic Kidney Disease Epidemiology Collaboration < 50 mL min/1.73 m2) or outpatient antibiotic therapy were excluded. Dose, renal function, and blood draw procedures were assessed for each measured vancomycin sample. Initially, 121 samples were included. Subsequently, 7 samples, 6 of which with concentrations ≥ 40 mg/L, were verified to be incorrectly drawn and excluded. With doses of 40-50 mg/kg/day concentrations ranged from 18.4-61.0 mg/L. Only 25% were within the target window of 17-25 mg/L and 15% were ≥ 40 mg/L. Supratherapeutic concentrations were observed in 89% of samples from patients dosed 40-60 mg/kg/day with eGFR 50-80 mL/min. Concluding, an empiric dosing regimen of 45 mg/kg results in too high vancomycin exposure and thus we recommend lower doses and differentiation according to renal function. Additionally, when measuring concentrations over 40 mg/L incorrect sampling must be excluded before dose adjustment and the large variability in exposure between patients, warrants the need for swift TDM.

来源:Clin Pharmacol Ther,查看原文。版权归原作者所有。

引用

  1. Derijks-Engwegen JYMN, Jager NGL. Dosing and Exposure of Vancomycin With Continuous Infusion: A Retrospective Study. Clin Pharmacol Ther. 2024. PMID: 38409960. doi:10.1002/cpt.3221

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。